Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions
The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two hu...
Saved in:
Published in | Nature communications Vol. 11; no. 1; pp. 1528 - 14 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
23.03.2020
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/s41467-020-15271-3 |
Cover
Loading…
Abstract | The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.
Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions. |
---|---|
AbstractList | The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations. The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations. The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations. Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions. The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions. Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions. |
ArticleNumber | 1528 |
Author | Yusa, Kosuke Andrews, Simon Andrews, Peter W. Reik, Wolf Thompson, Oliver Moore, Harry D. Krueger, Felix Alexander, John Wood, Andrew von Meyenn, Ferdinand Barbaric, Ivana Hewitt, Zoe Milo, Marta Gregory, Sian Nik-Zainal, Serena Weightman, Richard Gokhale, Paul J. |
Author_xml | – sequence: 1 givenname: Oliver surname: Thompson fullname: Thompson, Oliver organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 2 givenname: Ferdinand orcidid: 0000-0001-9920-3075 surname: von Meyenn fullname: von Meyenn, Ferdinand organization: Epigenetics Programme, Babraham Institute, Department of Medical & Molecular Genetics, King’s College London, Institute of Food, Nutrition and Health, ETH Zurich – sequence: 3 givenname: Zoe orcidid: 0000-0001-7519-7029 surname: Hewitt fullname: Hewitt, Zoe organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 4 givenname: John orcidid: 0000-0003-3973-6501 surname: Alexander fullname: Alexander, John organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research – sequence: 5 givenname: Andrew orcidid: 0000-0002-5973-2092 surname: Wood fullname: Wood, Andrew organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 6 givenname: Richard orcidid: 0000-0002-2593-8631 surname: Weightman fullname: Weightman, Richard organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 7 givenname: Sian orcidid: 0000-0002-3014-2603 surname: Gregory fullname: Gregory, Sian organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 8 givenname: Felix orcidid: 0000-0002-5513-3324 surname: Krueger fullname: Krueger, Felix organization: Bioinformatics Group, Babraham Institute – sequence: 9 givenname: Simon surname: Andrews fullname: Andrews, Simon organization: Bioinformatics Group, Babraham Institute – sequence: 10 givenname: Ivana surname: Barbaric fullname: Barbaric, Ivana organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 11 givenname: Paul J. orcidid: 0000-0001-7225-4403 surname: Gokhale fullname: Gokhale, Paul J. organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 12 givenname: Harry D. surname: Moore fullname: Moore, Harry D. organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 13 givenname: Wolf surname: Reik fullname: Reik, Wolf organization: Epigenetics Programme, Babraham Institute, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton – sequence: 14 givenname: Marta orcidid: 0000-0002-6996-6431 surname: Milo fullname: Milo, Marta organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank – sequence: 15 givenname: Serena orcidid: 0000-0001-5054-1727 surname: Nik-Zainal fullname: Nik-Zainal, Serena organization: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Academic Laboratory of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Box 238, Lv6 Addenbrooke’ Treatment Centre, Cambridge Biomedical Research Campus, MRC Cancer Unit, University of Cambridge, Hutchinson/MRC Research Centre, Box 1297, Cambridge Biomedical Campus – sequence: 16 givenname: Kosuke orcidid: 0000-0002-3442-021X surname: Yusa fullname: Yusa, Kosuke email: k.yusa@infront.kyoto-u.ac.jp organization: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Institute for Frontier Life and Medical Sciences, Kyoto University – sequence: 17 givenname: Peter W. orcidid: 0000-0001-7215-4410 surname: Andrews fullname: Andrews, Peter W. email: p.w.andrews@sheffield.ac.uk organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32251294$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1vFSEUnZgaW2v_gAtD4sbNKJ_DsDExja1NXuJG1wQYmPLCwBNmbPz3Mp1W2y56NxDuOSeHe8_r5iimaJvmLYIfEST9p0IR7XgLMWwRwxy15EVzgiFFLeKYHD24HzdnpexhLSJQT-mr5phgzBAW9KQZd-kGZDXbApID0zKr2acIfAQm-OiNCmDMarDgeplUBIewZH9Is40zKLOdgLEhFLDEwWYweOdsXltmCfOSLTApDn4VLG-al06FYs_uztPm58XXH-ff2t33y6vzL7vWMArnVg-aGeV0NS-EoNgJqxUXDBIGRedc1w1EC2XQIJjodUe4GgxnEDmotcWInDZXm-6Q1F4esp9U_iOT8vL2IeVRqjx7E6zsHGMWQs4rm0JENFFcC44o6XRfq2p93rQOi57sYOrPsgqPRB93or-WY_otOeyF6HgV-HAnkNOvxZZZTr6sE1PRpqVITHqOGWH96vv9E-g-LTnWUa0oDAlFsKuodw8d_bNyv88K6DeAyamUbJ00fltpNeiDRFCu6ZFbemRNj7xNjySVip9Q79WfJZGNVCo4jjb_t_0M6y-1Dtcv |
CitedBy_id | crossref_primary_10_1016_j_xpro_2025_103630 crossref_primary_10_1134_S0006297924050031 crossref_primary_10_1002_adbi_202400538 crossref_primary_10_3390_biomedicines10051204 crossref_primary_10_1016_j_stem_2021_07_012 crossref_primary_10_1039_D4FO03078H crossref_primary_10_1038_s41419_022_05413_4 crossref_primary_10_1089_scd_2021_0013 crossref_primary_10_1016_j_jcyt_2022_08_001 crossref_primary_10_3389_fphys_2023_1331974 crossref_primary_10_3390_cells13161395 crossref_primary_10_1186_s12864_024_10329_8 crossref_primary_10_1038_s12276_024_01334_8 crossref_primary_10_3390_genes14061291 crossref_primary_10_1016_j_psj_2023_103280 crossref_primary_10_1111_cpr_12892 crossref_primary_10_1038_s41598_024_77972_9 crossref_primary_10_1016_j_stemcr_2024_08_004 crossref_primary_10_31857_S0320972524050036 crossref_primary_10_3390_ijms241310871 crossref_primary_10_1186_s12864_022_08479_8 crossref_primary_10_1016_j_stem_2022_11_006 crossref_primary_10_2217_rme_2021_0013 crossref_primary_10_1038_s41588_022_01147_3 crossref_primary_10_3390_ani13010127 crossref_primary_10_1016_j_cbpb_2021_110570 crossref_primary_10_1016_j_stemcr_2023_05_004 crossref_primary_10_1093_gbe_evab148 crossref_primary_10_1089_crispr_2022_0050 crossref_primary_10_1093_nar_gkad775 crossref_primary_10_1007_s12033_024_01259_7 crossref_primary_10_3390_cells10113246 crossref_primary_10_1016_j_cbd_2024_101336 crossref_primary_10_1016_j_aquaculture_2024_741173 crossref_primary_10_1007_s11427_023_2354_6 crossref_primary_10_3390_plants12030538 crossref_primary_10_1016_j_intimp_2024_113876 crossref_primary_10_1038_s41423_024_01213_2 crossref_primary_10_1016_j_biomaterials_2023_122033 crossref_primary_10_1177_10732748241270564 crossref_primary_10_1016_j_stemcr_2023_01_007 crossref_primary_10_1093_nar_gkab914 crossref_primary_10_1016_j_regen_2024_100078 crossref_primary_10_1016_j_isci_2022_103736 crossref_primary_10_1089_scd_2021_0079 crossref_primary_10_1016_j_ijbiomac_2024_135067 crossref_primary_10_1016_j_plaphy_2025_109828 crossref_primary_10_1002_2211_5463_13581 crossref_primary_10_1615_CritRevOncog_2022042332 crossref_primary_10_1038_s41580_020_00292_z crossref_primary_10_3390_ijms231810924 crossref_primary_10_1155_2021_5575185 crossref_primary_10_1073_pnas_2305187120 crossref_primary_10_1016_j_stemcr_2020_04_004 crossref_primary_10_1038_s12276_022_00907_9 crossref_primary_10_5483_BMBRep_2021_54_10_094 crossref_primary_10_1016_j_stemcr_2022_01_019 crossref_primary_10_1016_j_arr_2021_101316 crossref_primary_10_1016_j_scienta_2024_113521 crossref_primary_10_34133_bmr_0093 crossref_primary_10_1007_s11626_024_00865_8 crossref_primary_10_1038_s41598_021_95224_y crossref_primary_10_3390_ijms23020855 crossref_primary_10_1016_j_xpro_2020_100213 crossref_primary_10_1016_j_postharvbio_2024_112849 crossref_primary_10_1007_s11103_024_01448_7 crossref_primary_10_2147_JIR_S495512 crossref_primary_10_1080_14712598_2023_2225701 crossref_primary_10_3389_fnmol_2023_1173433 crossref_primary_10_3390_cells11131984 crossref_primary_10_1016_j_aqrep_2024_102494 crossref_primary_10_1038_s41598_021_03658_1 crossref_primary_10_3390_antiox13121545 crossref_primary_10_1016_j_stemcr_2023_11_013 |
Cites_doi | 10.1016/j.stem.2013.06.004 10.1371/journal.pgen.1005932 10.1016/j.stemcr.2013.10.005 10.1038/ncomms15183 10.1016/j.cell.2019.03.001 10.1089/clo.2006.8.16 10.1016/j.cell.2012.04.024 10.1038/nbt.2051 10.1016/j.stemcr.2014.05.006 10.1089/scd.2013.0504 10.1038/nature08658 10.1038/nbt.1510 10.1093/molehr/gat077 10.1038/nbt1285 10.1016/j.scr.2009.09.001 10.1371/journal.pone.0078847 10.1038/nature23286 10.1038/nrm2354 10.1016/j.stemcr.2016.10.003 10.1016/j.stem.2012.02.014 10.1016/j.devcel.2016.09.015 10.1016/j.celrep.2018.06.091 10.1371/journal.pone.0118307 10.1016/j.stem.2016.01.019 10.1038/s41467-018-04052-8 10.1242/dev.146811 10.1002/stem.1117 10.1093/hmg/ddm074 10.1093/nar/gky1015 10.1038/nature22312 10.1073/pnas.062527199 10.1038/nrm.2016.88 10.1093/hmg/ddi345 10.1093/bioinformatics/btr167 10.1093/hmg/ddm245 10.1016/j.stemcr.2016.01.015 10.1016/j.stemcr.2017.05.029 10.1038/ng.3991 10.1016/j.stemcr.2016.02.005 10.1007/s12015-016-9662-8 10.1038/nbt.1509 10.1101/gr.6609207 10.1056/NEJMc1706274 10.1038/embor.2012.165 10.1038/nbt922 10.1038/nature12477 10.1038/ncomms10536 10.1016/j.cell.2019.02.012 10.1038/nbt1310 10.1093/bioinformatics/btv408 10.1101/430165 10.1002/stem.451 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-020-15271-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Biological Science Database ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_6f55e007701f4013b3a7b971436b8888 PMC7089967 32251294 10_1038_s41467_020_15271_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Cancer Research UK grantid: 22932 – fundername: Medical Research Council grantid: MR/L012537/1 – fundername: Cancer Research UK grantid: 23433 – fundername: Cancer Research UK grantid: 23916 – fundername: Cancer Research UK grantid: 27815 – fundername: Wellcome Trust grantid: 206194 – fundername: Wellcome Trust grantid: WT206194 – fundername: Cancer Research UK grantid: A23916 |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c540t-bdb5cafb20499942f9eba795035096ff66d3b9ac1d9598b637adc7501f0bbe213 |
IEDL.DBID | BENPR |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:27:17 EDT 2025 Thu Aug 21 14:35:21 EDT 2025 Thu Sep 04 19:50:13 EDT 2025 Wed Aug 13 04:04:15 EDT 2025 Mon Jul 21 06:05:18 EDT 2025 Thu Apr 24 23:07:17 EDT 2025 Tue Jul 01 04:08:53 EDT 2025 Fri Feb 21 02:40:11 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-bdb5cafb20499942f9eba795035096ff66d3b9ac1d9598b637adc7501f0bbe213 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5054-1727 0000-0003-3973-6501 0000-0002-6996-6431 0000-0001-7215-4410 0000-0002-5513-3324 0000-0002-5973-2092 0000-0002-2593-8631 0000-0001-7225-4403 0000-0002-3014-2603 0000-0001-9920-3075 0000-0002-3442-021X 0000-0001-7519-7029 |
OpenAccessLink | https://www.proquest.com/docview/2382034106?pq-origsite=%requestingapplication% |
PMID | 32251294 |
PQID | 2382034106 |
PQPubID | 546298 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6f55e007701f4013b3a7b971436b8888 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7089967 proquest_miscellaneous_2387253581 proquest_journals_2382034106 pubmed_primary_32251294 crossref_citationtrail_10_1038_s41467_020_15271_3 crossref_primary_10_1038_s41467_020_15271_3 springer_journals_10_1038_s41467_020_15271_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-03-23 |
PublicationDateYYYYMMDD | 2020-03-23 |
PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Guo (CR31) 2017; 144 Lefort (CR9) 2008; 26 Garitaonandia (CR34) 2015; 10 Watanabe (CR49) 2007; 25 Forsyth (CR35) 2006; 8 Bhutani (CR11) 2016; 7 Simon, Keith (CR39) 2008; 9 Cervantes, Stringer, Shao, Tischfield, Stambrook (CR33) 2002; 99 Frigola (CR23) 2017; 49 Gehring, Fischer, Lawrence, Huber (CR52) 2015; 31 Kucab (CR41) 2019; 177 Draper (CR6) 2004; 22 Nguyen (CR16) 2014; 20 D’Antonio (CR40) 2018; 24 Pastor (CR32) 2016; 18 Fynes (CR37) 2014; 23 Barta (CR19) 2010; 28 Krueger, Andrews (CR51) 2011; 27 Tate (CR53) 2019; 47 Baker (CR4) 2016; 7 Spits (CR10) 2008; 26 von Meyenn (CR50) 2016; 39 Baker (CR7) 2007; 25 Avery (CR15) 2013; 1 Rugg-Gunn, Ferguson-Smith, Pedersen (CR30) 2007; 16 Zou (CR42) 2018; 9 Alexandrov (CR25) 2013; 500 Garcia-Muse, Aguilera (CR27) 2016; 17 Milholland (CR17) 2017; 8 Petljak (CR26) 2019; 176 Barbaric (CR14) 2014; 3 Jacobs (CR36) 2016; 6 Mandai, Kurimoto, Takahashi (CR1) 2017; 377 Olariu (CR13) 2010; 4 CR18 Guo (CR48) 2016; 6 Andrews (CR5) 2017; 9 Allegrucci (CR44) 2007; 16 Desmarais (CR20) 2012; 30 Pleasance (CR22) 2010; 463 Enver (CR28) 2005; 14 Kim (CR45) 2007; 17 Nik-Zainal (CR24) 2012; 149 Narva (CR38) 2013; 8 Amps (CR2) 2011; 29 Baghbaderani (CR8) 2016; 12 Ficz (CR46) 2013; 13 Mekhoubad (CR29) 2012; 10 CR21 Yagi (CR47) 2017; 548 Park, Qian, Zhang (CR43) 2012; 13 Merkle (CR12) 2017; 545 Rouhani (CR3) 2016; 12 B Milholland (15271_CR17) 2017; 8 HT Nguyen (15271_CR16) 2014; 20 M D’Antonio (15271_CR40) 2018; 24 MC Simon (15271_CR39) 2008; 9 C Allegrucci (15271_CR44) 2007; 16 I Garitaonandia (15271_CR34) 2015; 10 DE Baker (15271_CR7) 2007; 25 FJ Rouhani (15271_CR3) 2016; 12 K Bhutani (15271_CR11) 2016; 7 FT Merkle (15271_CR12) 2017; 545 PJ Rugg-Gunn (15271_CR30) 2007; 16 V Olariu (15271_CR13) 2010; 4 S Nik-Zainal (15271_CR24) 2012; 149 LB Alexandrov (15271_CR25) 2013; 500 JS Gehring (15271_CR52) 2015; 31 JG Tate (15271_CR53) 2019; 47 KP Kim (15271_CR45) 2007; 17 PW Andrews (15271_CR5) 2017; 9 JS Draper (15271_CR6) 2004; 22 J Frigola (15271_CR23) 2017; 49 M Petljak (15271_CR26) 2019; 176 K Jacobs (15271_CR36) 2016; 6 RB Cervantes (15271_CR33) 2002; 99 T Enver (15271_CR28) 2005; 14 M Mandai (15271_CR1) 2017; 377 BA Baghbaderani (15271_CR8) 2016; 12 F Krueger (15271_CR51) 2011; 27 JE Kucab (15271_CR41) 2019; 177 NR Forsyth (15271_CR35) 2006; 8 E Narva (15271_CR38) 2013; 8 S Avery (15271_CR15) 2013; 1 15271_CR21 S Mekhoubad (15271_CR29) 2012; 10 X Zou (15271_CR42) 2018; 9 M Yagi (15271_CR47) 2017; 548 F von Meyenn (15271_CR50) 2016; 39 C Park (15271_CR43) 2012; 13 ED Pleasance (15271_CR22) 2010; 463 K Fynes (15271_CR37) 2014; 23 N Lefort (15271_CR9) 2008; 26 T Barta (15271_CR19) 2010; 28 K Amps (15271_CR2) 2011; 29 K Watanabe (15271_CR49) 2007; 25 G Guo (15271_CR31) 2017; 144 15271_CR18 WA Pastor (15271_CR32) 2016; 18 G Guo (15271_CR48) 2016; 6 T Garcia-Muse (15271_CR27) 2016; 17 C Spits (15271_CR10) 2008; 26 I Barbaric (15271_CR14) 2014; 3 JA Desmarais (15271_CR20) 2012; 30 G Ficz (15271_CR46) 2013; 13 D Baker (15271_CR4) 2016; 7 |
References_xml | – volume: 13 start-page: 351 year: 2013 end-page: 359 ident: CR46 article-title: FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.06.004 – volume: 12 start-page: e1005932 year: 2016 ident: CR3 article-title: Mutational history of a human cell lineage from somatic to induced pluripotent stem cells publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1005932 – volume: 1 start-page: 379 year: 2013 end-page: 386 ident: CR15 article-title: BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2013.10.005 – volume: 8 year: 2017 ident: CR17 article-title: Differences between germline and somatic mutation rates in humans and mice publication-title: Nat. Commun. doi: 10.1038/ncomms15183 – volume: 177 start-page: 821 year: 2019 end-page: 836 e816 ident: CR41 article-title: A compendium of mutational signatures of environmental agents publication-title: Cell doi: 10.1016/j.cell.2019.03.001 – volume: 8 start-page: 16 year: 2006 end-page: 23 ident: CR35 article-title: Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities publication-title: Cloning Stem Cells doi: 10.1089/clo.2006.8.16 – volume: 149 start-page: 979 year: 2012 end-page: 993 ident: CR24 article-title: Mutational processes molding the genomes of 21 breast cancers publication-title: Cell doi: 10.1016/j.cell.2012.04.024 – volume: 29 start-page: 1132 year: 2011 end-page: 1144 ident: CR2 article-title: Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2051 – volume: 3 start-page: 142 year: 2014 end-page: 155 ident: CR14 article-title: Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2014.05.006 – volume: 23 start-page: 1910 year: 2014 end-page: 1922 ident: CR37 article-title: The differential effects of 2% oxygen preconditioning on the subsequent differentiation of mouse and human pluripotent stem cells publication-title: Stem Cells Dev. doi: 10.1089/scd.2013.0504 – volume: 31 start-page: 3673 year: 2015 end-page: 3675 ident: CR52 article-title: SomaticSignatures: inferring mutational signatures from single-nucleotide variants publication-title: Bioinformatics – volume: 463 start-page: 191 year: 2010 end-page: 196 ident: CR22 article-title: A comprehensive catalogue of somatic mutations from a human cancer genome publication-title: Nature doi: 10.1038/nature08658 – volume: 26 start-page: 1361 year: 2008 end-page: 1363 ident: CR10 article-title: Recurrent chromosomal abnormalities in human embryonic stem cells publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1510 – volume: 20 start-page: 168 year: 2014 end-page: 177 ident: CR16 article-title: Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL publication-title: Mol. Hum. Reprod. doi: 10.1093/molehr/gat077 – ident: CR21 – volume: 25 start-page: 207 year: 2007 end-page: 215 ident: CR7 article-title: Adaptation to culture of human embryonic stem cells and oncogenesis in vivo publication-title: Nat. Biotechnol. doi: 10.1038/nbt1285 – volume: 4 start-page: 50 year: 2010 end-page: 56 ident: CR13 article-title: Modeling the evolution of culture-adapted human embryonic stem cells publication-title: Stem Cell Res. doi: 10.1016/j.scr.2009.09.001 – volume: 8 start-page: e78847 year: 2013 ident: CR38 article-title: Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels publication-title: PLoS ONE doi: 10.1371/journal.pone.0078847 – volume: 548 start-page: 224 year: 2017 end-page: 227 ident: CR47 article-title: Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation publication-title: Nature doi: 10.1038/nature23286 – volume: 9 start-page: 285 year: 2008 end-page: 296 ident: CR39 article-title: The role of oxygen availability in embryonic development and stem cell function publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2354 – volume: 7 start-page: 998 year: 2016 end-page: 1012 ident: CR4 article-title: Detecting genetic mosaicism in cultures of human pluripotent stem cells publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.10.003 – volume: 10 start-page: 595 year: 2012 end-page: 609 ident: CR29 article-title: Erosion of dosage compensation impacts human iPSC disease modeling publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.02.014 – volume: 39 start-page: 104 year: 2016 end-page: 115 ident: CR50 article-title: Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification publication-title: Dev. Cell doi: 10.1016/j.devcel.2016.09.015 – volume: 24 start-page: 883 year: 2018 end-page: 894 ident: CR40 article-title: Insights into the mutational burden of human induced pluripotent stem cells from an integrative multi-omics approach publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.06.091 – volume: 10 start-page: e0118307 year: 2015 ident: CR34 article-title: Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions publication-title: PLoS ONE doi: 10.1371/journal.pone.0118307 – volume: 18 start-page: 323 year: 2016 end-page: 329 ident: CR32 article-title: Naive human pluripotent cells feature a methylation landscape devoid of blastocyst or germline memory publication-title: Cell Stem Cell doi: 10.1016/j.stem.2016.01.019 – ident: CR18 – volume: 9 year: 2018 ident: CR42 article-title: Validating the concept of mutational signatures with isogenic cell models publication-title: Nat. Commun. doi: 10.1038/s41467-018-04052-8 – volume: 144 start-page: 2748 year: 2017 end-page: 2763 ident: CR31 article-title: Epigenetic resetting of human pluripotency publication-title: Development doi: 10.1242/dev.146811 – volume: 30 start-page: 1385 year: 2012 end-page: 1393 ident: CR20 article-title: Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress publication-title: Stem Cells doi: 10.1002/stem.1117 – volume: 16 start-page: 1253 year: 2007 end-page: 1268 ident: CR44 article-title: Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm074 – volume: 47 start-page: D941 year: 2019 end-page: D947 ident: CR53 article-title: COSMIC: the catalogue of somatic mutations in cancer publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1015 – volume: 545 start-page: 229 year: 2017 end-page: 233 ident: CR12 article-title: Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations publication-title: Nature doi: 10.1038/nature22312 – volume: 99 start-page: 3586 year: 2002 end-page: 3590 ident: CR33 article-title: Embryonic stem cells and somatic cells differ in mutation frequency and type publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.062527199 – volume: 17 start-page: 553 year: 2016 end-page: 563 ident: CR27 article-title: Transcription-replication conflicts: how they occur and how they are resolved publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm.2016.88 – volume: 28 start-page: 1143 year: 2010 end-page: 1152 ident: CR19 article-title: Human embryonic stem cells are capable of executing G1/S checkpoint activation publication-title: Stem Cells – volume: 14 start-page: 3129 year: 2005 end-page: 3140 ident: CR28 article-title: Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddi345 – volume: 27 start-page: 1571 year: 2011 end-page: 1572 ident: CR51 article-title: Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr167 – volume: 16 start-page: R243 issue: Spec No. 2 year: 2007 end-page: R251 ident: CR30 article-title: Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm245 – volume: 6 start-page: 330 year: 2016 end-page: 341 ident: CR36 article-title: Higher-density culture in human embryonic stem cells results in DNA damage and genome instability publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.01.015 – volume: 9 start-page: 1 year: 2017 end-page: 4 ident: CR5 article-title: Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2017.05.029 – volume: 49 start-page: 1684 year: 2017 end-page: 1692 ident: CR23 article-title: Reduced mutation rate in exons due to differential mismatch repair publication-title: Nat. Genet. doi: 10.1038/ng.3991 – volume: 6 start-page: 437 year: 2016 end-page: 446 ident: CR48 article-title: Naive pluripotent stem cells derived directly from isolated cells of the human inner cell mass publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.02.005 – volume: 12 start-page: 394 year: 2016 end-page: 420 ident: CR8 article-title: Detailed characterization of human induced pluripotent stem cells manufactured for therapeutic applications publication-title: Stem Cell Rev. doi: 10.1007/s12015-016-9662-8 – volume: 26 start-page: 1364 year: 2008 end-page: 1366 ident: CR9 article-title: Human embryonic stem cells reveal recurrent genomic instability at 20q11.21 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1509 – volume: 17 start-page: 1731 year: 2007 end-page: 1742 ident: CR45 article-title: Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines publication-title: Genome Res. doi: 10.1101/gr.6609207 – volume: 377 start-page: 792 year: 2017 end-page: 793 ident: CR1 article-title: Autologous induced stem-cell-derived retinal cells for macular degeneration publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc1706274 – volume: 13 start-page: 1123 year: 2012 end-page: 1129 ident: CR43 article-title: Genomic evidence for elevated mutation rates in highly expressed genes publication-title: EMBO Rep. doi: 10.1038/embor.2012.165 – volume: 22 start-page: 53 year: 2004 end-page: 54 ident: CR6 article-title: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells publication-title: Nat. Biotechnol. doi: 10.1038/nbt922 – volume: 500 start-page: 415 year: 2013 end-page: 421 ident: CR25 article-title: Signatures of mutational processes in human cancer publication-title: Nature doi: 10.1038/nature12477 – volume: 7 year: 2016 ident: CR11 article-title: Whole-genome mutational burden analysis of three pluripotency induction methods publication-title: Nat. Commun. doi: 10.1038/ncomms10536 – volume: 176 start-page: 1282 year: 2019 end-page: 1294 e1220 ident: CR26 article-title: Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis publication-title: Cell doi: 10.1016/j.cell.2019.02.012 – volume: 25 start-page: 681 year: 2007 end-page: 686 ident: CR49 article-title: A ROCK inhibitor permits survival of dissociated human embryonic stem cells publication-title: Nat. Biotechnol. doi: 10.1038/nbt1310 – volume: 99 start-page: 3586 year: 2002 ident: 15271_CR33 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.062527199 – volume: 9 start-page: 1 year: 2017 ident: 15271_CR5 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2017.05.029 – volume: 16 start-page: R243 issue: Spec No. 2 year: 2007 ident: 15271_CR30 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm245 – volume: 3 start-page: 142 year: 2014 ident: 15271_CR14 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2014.05.006 – volume: 177 start-page: 821 year: 2019 ident: 15271_CR41 publication-title: Cell doi: 10.1016/j.cell.2019.03.001 – volume: 17 start-page: 1731 year: 2007 ident: 15271_CR45 publication-title: Genome Res. doi: 10.1101/gr.6609207 – volume: 10 start-page: e0118307 year: 2015 ident: 15271_CR34 publication-title: PLoS ONE doi: 10.1371/journal.pone.0118307 – volume: 26 start-page: 1364 year: 2008 ident: 15271_CR9 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1509 – volume: 29 start-page: 1132 year: 2011 ident: 15271_CR2 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2051 – volume: 20 start-page: 168 year: 2014 ident: 15271_CR16 publication-title: Mol. Hum. Reprod. doi: 10.1093/molehr/gat077 – volume: 8 start-page: 16 year: 2006 ident: 15271_CR35 publication-title: Cloning Stem Cells doi: 10.1089/clo.2006.8.16 – volume: 8 start-page: e78847 year: 2013 ident: 15271_CR38 publication-title: PLoS ONE doi: 10.1371/journal.pone.0078847 – volume: 7 year: 2016 ident: 15271_CR11 publication-title: Nat. Commun. doi: 10.1038/ncomms10536 – volume: 8 year: 2017 ident: 15271_CR17 publication-title: Nat. Commun. doi: 10.1038/ncomms15183 – volume: 23 start-page: 1910 year: 2014 ident: 15271_CR37 publication-title: Stem Cells Dev. doi: 10.1089/scd.2013.0504 – volume: 12 start-page: 394 year: 2016 ident: 15271_CR8 publication-title: Stem Cell Rev. doi: 10.1007/s12015-016-9662-8 – volume: 31 start-page: 3673 year: 2015 ident: 15271_CR52 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv408 – volume: 49 start-page: 1684 year: 2017 ident: 15271_CR23 publication-title: Nat. Genet. doi: 10.1038/ng.3991 – volume: 9 year: 2018 ident: 15271_CR42 publication-title: Nat. Commun. doi: 10.1038/s41467-018-04052-8 – volume: 24 start-page: 883 year: 2018 ident: 15271_CR40 publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.06.091 – volume: 14 start-page: 3129 year: 2005 ident: 15271_CR28 publication-title: Hum. Mol. Genet doi: 10.1093/hmg/ddi345 – volume: 47 start-page: D941 year: 2019 ident: 15271_CR53 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gky1015 – volume: 548 start-page: 224 year: 2017 ident: 15271_CR47 publication-title: Nature doi: 10.1038/nature23286 – ident: 15271_CR21 – volume: 18 start-page: 323 year: 2016 ident: 15271_CR32 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2016.01.019 – volume: 16 start-page: 1253 year: 2007 ident: 15271_CR44 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm074 – volume: 545 start-page: 229 year: 2017 ident: 15271_CR12 publication-title: Nature doi: 10.1038/nature22312 – volume: 30 start-page: 1385 year: 2012 ident: 15271_CR20 publication-title: Stem Cells doi: 10.1002/stem.1117 – volume: 500 start-page: 415 year: 2013 ident: 15271_CR25 publication-title: Nature doi: 10.1038/nature12477 – volume: 26 start-page: 1361 year: 2008 ident: 15271_CR10 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1510 – volume: 176 start-page: 1282 year: 2019 ident: 15271_CR26 publication-title: Cell doi: 10.1016/j.cell.2019.02.012 – volume: 149 start-page: 979 year: 2012 ident: 15271_CR24 publication-title: Cell doi: 10.1016/j.cell.2012.04.024 – volume: 22 start-page: 53 year: 2004 ident: 15271_CR6 publication-title: Nat. Biotechnol. doi: 10.1038/nbt922 – volume: 6 start-page: 330 year: 2016 ident: 15271_CR36 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.01.015 – volume: 9 start-page: 285 year: 2008 ident: 15271_CR39 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2354 – volume: 27 start-page: 1571 year: 2011 ident: 15271_CR51 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr167 – volume: 1 start-page: 379 year: 2013 ident: 15271_CR15 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2013.10.005 – ident: 15271_CR18 doi: 10.1101/430165 – volume: 144 start-page: 2748 year: 2017 ident: 15271_CR31 publication-title: Development doi: 10.1242/dev.146811 – volume: 463 start-page: 191 year: 2010 ident: 15271_CR22 publication-title: Nature doi: 10.1038/nature08658 – volume: 25 start-page: 681 year: 2007 ident: 15271_CR49 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1310 – volume: 10 start-page: 595 year: 2012 ident: 15271_CR29 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.02.014 – volume: 17 start-page: 553 year: 2016 ident: 15271_CR27 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm.2016.88 – volume: 4 start-page: 50 year: 2010 ident: 15271_CR13 publication-title: Stem Cell Res. doi: 10.1016/j.scr.2009.09.001 – volume: 13 start-page: 1123 year: 2012 ident: 15271_CR43 publication-title: EMBO Rep. doi: 10.1038/embor.2012.165 – volume: 28 start-page: 1143 year: 2010 ident: 15271_CR19 publication-title: Stem Cells doi: 10.1002/stem.451 – volume: 377 start-page: 792 year: 2017 ident: 15271_CR1 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc1706274 – volume: 7 start-page: 998 year: 2016 ident: 15271_CR4 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.10.003 – volume: 12 start-page: e1005932 year: 2016 ident: 15271_CR3 publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1005932 – volume: 13 start-page: 351 year: 2013 ident: 15271_CR46 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.06.004 – volume: 25 start-page: 207 year: 2007 ident: 15271_CR7 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1285 – volume: 39 start-page: 104 year: 2016 ident: 15271_CR50 publication-title: Dev. Cell doi: 10.1016/j.devcel.2016.09.015 – volume: 6 start-page: 437 year: 2016 ident: 15271_CR48 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2016.02.005 |
SSID | ssj0000391844 |
Score | 2.5894465 |
Snippet | The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application.... Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1528 |
SubjectTerms | 13/100 38/23 38/70 49/47 631/114/2403 631/208/176/1988 631/208/726/649 631/532/2064/2117 Cell culture Cell Culture Techniques - methods Cell Line Cell lines Chromatin Chromosomes Chromosomes, Human, X - genetics Culture Culture Media - pharmacology Cyclic GMP Deoxyribonucleic acid DNA DNA Methylation DNA Mutational Analysis DNA, Intergenic - genetics Enzyme inhibitors Epigenesis, Genetic Humanities and Social Sciences Humans Kinases multidisciplinary Mutation Mutation Rate Mutation rates Oxidative Stress - drug effects Oxidative Stress - genetics Oxygen Oxygen - chemistry Oxygen - pharmacology Pluripotency Pluripotent Stem Cells - physiology Rho-associated kinase Science Science (multidisciplinary) Sequence Analysis, RNA Stem cells Whole Genome Sequencing |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEB9kQfAirp_VVSJ407JtkibNUcVlEfXkwt5C0ibrwtou7_Uh_vc7k7TPfX5ePLZNIMxMJr_pZH4D8EKFtkbHiMYrXFVK2fvSS6dLo6R3fcDnhgqFP35Sxyfy_Wlzeq3VF90Jy_TAWXCHKjZNINKZqo4UC3jhtDfUtVt5jN5SmS-eedeCqeSDhcHQRc5VMpVoD9cy-QSKlqiTa12KnZMoEfb_DmX-elnyp4xpOoiO7sDtGUGy13nl-3AjDHfhZu4p-f0enH0YvzHif1izMbKvm5xqZ-cDW4og2dkK5cNSdz52ebFBtzEicp4YcToz-pO_ZlRatmJL95SJZYKOwDB67vMlr_twcvTu89vjcu6mUHaIyqbSo9g7Fz1PQY7k0QTvtGkotWhUjEr1whvX1b1pTOuV0K7vEE_UsfI-8Fo8gL1hHMIjYNFhEKkNiqQ30lcRp_OuRezFeR21DgXUi2RtN1ONU8eLC5tS3qK1WRsWtWGTNqwo4OV2zmUm2vjr6DeksO1IIslOL9B07Gw69l-mU8DBom4779y1RQjDKzzaK1XA8-1n3HMkfjeEcZPGaN4Qc1wBD7N1bFdCDhIxlCxA79jNzlJ3vwznXxKvt6YUrNIFvFos7Mey_iyKx_9DFE_gFqetUYmSiwPYm1ab8BTR1uSfpY11BShQI4U priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIiQuiDcpBRmJGwQSO7HjA0KAqCpEObFSb5ad2NtKS1Kyuyr998w4yaKFpXvLxpacedjfZDLfALyUvspxY0TjFTZLi6JxqSusSrUsnG08XpdUKHzyTR7Pii-n5ekeTO2ORgEud4Z21E9q1i_e_Pp59R4d_t1QMl69XRbR3SkQoiateSpuwE08mSRZ-ckI9-POLDQGNMVYO7N76tb5FGn8d2HPfz-h_CuPGo-no7twZ8SV7MNgCPdgz7f34dbQafLqAcy_dpeMWCGWrAvsx3pIwLPzlk2lkWzeo9RY7NnHLhZr3Ew6xNMrRkzPjN7vLxkVnPVs6qmyYgNth2cYUzfDp18PYXb0-fun43TssZDWiNVWqUNl1DY4HkOfggftnVW6pISjliFI2QinbZ03utSVk0LZpkaUkYfMOc9z8Qj22671T4AFi6Gl0iiSRhcuCzid1xUiMs7zoJRPIJ8ka-qRgJz6YCxMTISLygzaMKgNE7VhRAKvNnMuBvqNa0d_JIVtRhJ1dvyj6-dm9EQjQ1l6YjHCZ6Dg0gmrnKY28NJV-EvgcFK3mczRILDhGR74mUzgxeY2eiKJ37a-W8cxipfEJ5fA48E6NiuhbRORVZGA2rKbraVu32nPzyLbt6LErFQJvJ4s7M-y_i-Kg-uf4inc5mT0mUi5OIT9Vb_2zxBdrdzz6DK_AZakH-E priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8EX8dvqKRF802KbpEnzqIvHIeqTB_cWkjZZD-7aY7eL-N87k37I6in4uG0C2flIftPJ_AbglQp1iRsjGq9wRS5l63Mvnc6Nkt61AX9XVCj8-Ys6OZUfz6qzA-BzLUy6tJ8oLdM2Pd8Oe7uVyaUp2KFGrGUubsBNom4nvvyVWi3fVYjxvJZyqo8pRH3N1L0zKFH1X4cv_7wm-VuuNB1Bx3fhzoQd2btxtffgIHT34dbYTfLHA1h_6r8zYn7Ysj6yy92YZGfnHZvLH9l6g5JhqS8fu7rY4YbRI2YeGLE5M_qGv2VUVLZhc9-UgY3UHIFh3NyO17sewunxh6-rk3zqo5A3iMeG3KPAGxc9T-GN5NEE77SpKKloVIxKtcIb15StqUztldCubRBJlLHwPvBSPILDru_CE2DRYfioDYqkNdIXEafzpkbUxXkZtQ4ZlLNkbTORjFOviwubkt2itqM2LGrDJm1YkcHrZc7VSLHxz9HvSWHLSKLHTg_6zdpO5mJVrKpATEX4HyiA9MJpb6jVu_IY8tcZHM3qtpPPbi2CF17goV6oDF4ur9HbSPyuC_0ujdG8Is64DB6P1rGshLZGRE8yA71nN3tL3X_TnX9LjN6akq9KZ_BmtrBfy_q7KJ7-3_BncJuTExQi5-IIDofNLjxHRDX4F8mFfgLBqRp6 priority: 102 providerName: Springer Nature |
Title | Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions |
URI | https://link.springer.com/article/10.1038/s41467-020-15271-3 https://www.ncbi.nlm.nih.gov/pubmed/32251294 https://www.proquest.com/docview/2382034106 https://www.proquest.com/docview/2387253581 https://pubmed.ncbi.nlm.nih.gov/PMC7089967 https://doaj.org/article/6f55e007701f4013b3a7b971436b8888 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_WhMFexr7nrgsa7G0ztS1Zsp9GGpqVsJaxrZA3YdlyVujsNE4Y--93J3-U7KN-MNiWQbo7ne5D-h3AW2mTEBUjCi_PAl-IwvhGZMpPpTBZYfE5poPC5xfy7FIslvGyC7g13bbKXic6RV3UOcXIj3FpiQJUuYH8sL7xqWoUZVe7EhoHMEYVnMQjGJ-cXnz-MkRZCP88EaI7LRPw5LgRTjeQ10QVXUOf761IDrj_X9bm35sm_8icugVp_ggedpYkm7asfwz3bPUE7re1JX89hdWn-icjHIiG1SX7sWtT7uyqYv1hSLbaIJ2Yq9LH1tc7VB81WtBbRtjOjCL6DaMjZhvWV1HZshaowzL0oot2s9czuJyffpud-V1VBT9H62zrGyR_npUmcs6OiMrUmkylMaUYU1mWUhbcpFkeFmmcJkZylRU52hVhGRhjo5A_h1FVV_YlsDJDZ1KlSJIiFSYo8fcoT9AGi6KwVMp6EPaU1XkHOU6VL661S33zRLfc0MgN7bihuQfvhn_WLeDGna1PiGFDSwLLdi_qzUp3c0_LMo4t4RbhGMidNDxTJqXC79IkeHlw1LNbdzO40bfy5sGb4TPOPSJ_Vtl659qoKCYEOQ9etNIx9IQUJdpSwgO1Jzd7Xd3_Ul19d_jeilKxUnnwvpew2279nxSHd4_iFTyISOgD7kf8CEbbzc6-RntqayZwoJYK78n84wTG0-ni62LSTSR8O5OziYtU4P1cJL8BD5okEQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxLMEChgJThA1sR07OSDEa9nSbU-t1JuJE2epVJJlN6uqf4rfyIyTbLU8euvesnESZ16eyXi-AXipXBqjYUThFXkUSlna0Mpch5mSNi8dHidUKLx_oMZH8utxcrwBv4ZaGNpWOdhEb6jLpqBv5Du4tPAITW6k3s1-htQ1irKrQwuNTiz23PkZhmyLt7ufkL-vOB99Pvw4DvuuAmGB3kkbWnx8kVeWe2df8ipzNtdZQim2TFWVUqWwWV7EZZZkqVVC52WB62pcRdY6Hgu87zW4LoXICKs_HX1ZfdMhtPVUyr42JxLpzkJ6S0QxGvWPjUOxtv75NgH_8m3_3qL5R57WL3-jO3C791vZ-07Q7sKGq-_Bja6T5fl9mE6aM0aoEwvWVOzHskvws5OaDaWXbDpHrjDfE5DNTpdorBr011tGSNKM8gcLRgVtczb0bGlZBwviGMbsZbe17AEcXQm1H8Jm3dTuEbAqx9BVZ0iSMpM2qvByXqTo8XEeV1q7AOKBsqboAc6pz8ap8Yl2kZqOGwa5YTw3jAjg9eqaWQfvcenoD8Sw1UiC5vZ_NPOp6TXdqCpJHKEk4TtQ8GpFrm1GbeaVTfEXwPbAbtPbi4W5kO4AXqxOo6YT-fPaNUs_RvOE8OoC2OqkYzUTMsvouckA9JrcrE11_Ux98t2jiWtK_CodwJtBwi6m9X9SPL78LZ7DzfHh_sRMdg_2nsAtTgoQiZCLbdhs50v3FD251j7z6sPg21Xr6293_Foe |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG8CBYwEJ4g2sR07OSBEaVctLVWFqNSbGyf2Uqkkyz5U9a_x65jJY6vl0Vv3thtn5cx7Mp5vAF4rl8ZoGFF4RR6FUpY2tDLXYaakzUuH3xNqFP5yoHaO5Ofj5HgNfvW9MHSssreJjaEu64LekQ_RtfAITW6khr47FnG4Nfow-RnSBCmqtPbjNFoR2XMX55i-zd7vbiGv33A-2v72aSfsJgyEBUYq89DiVorcW94E_pL7zNlcZwmV2zLlvVKlsFlexGWWZKlVQudlgT429pG1jscC__cGrGv0iukA1je3Dw6_Lt_wEPZ6KmXXqROJdDiTjV2ijI2mycahWPGGzdCAf0W6fx_Y_KNq2zjD0V2400Wx7GMrdvdgzVX34WY71_LiAYz363NGGBQzVnv2Y9GW-9lpxfpGTDaeIo9YMyGQTc4WaLpqjN7njHClGVUTZoza26asn-AyZy1IiGOYwZftQbOHcHQt9H4Eg6qu3BNgPsdEVmdIkjKTNvJ4Oy9SjP84j73WLoC4p6wpOrhzmrpxZpqyu0hNyw2D3DANN4wI4O3ynkkL9nHl6k1i2HIlAXU3P9TTsen03iifJI4wk_AZKJW1Itc2o6Hzyqb4CWCjZ7fprMfMXMp6AK-Wl1Hvifx55epFs0bzhNDrAnjcSsdyJ2SkMY6TAegVuVnZ6uqV6vR7gy2uqQysdADvegm73Nb_SfH06qd4CbdQV83-7sHeM7jNSf4jEXKxAYP5dOGeY1g3ty86_WFwct0q-xuRA1-5 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low+rates+of+mutation+in+clinical+grade+human+pluripotent+stem+cells+under+different+culture+conditions&rft.jtitle=Nature+communications&rft.au=Thompson%2C+Oliver&rft.au=von+Meyenn+Ferdinand&rft.au=Hewitt%2C+Zoe&rft.au=Alexander%2C+John&rft.date=2020-03-23&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-020-15271-3&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |